Open Access
Issue
Med Sci (Paris)
Volume 35, Number 5, Mai 2019
Page(s) 419 - 422
Section Le Magazine
DOI https://doi.org/10.1051/medsci/2019085
Published online 22 May 2019
  1. Elkahatib N, Montagnac G. Une endocytose frustrée pour une migration accomplie Med Sci (Paris). 2018 ; 34 : 522–524. [Google Scholar]
  2. Hirata E, Girotti MR, Viros A, et al. Intravital imaging reveals how BRAF inhibition generates drug-tolerant microenvironments with high integrin β1/FAK signaling. Cancer Cell. 2015 ; 27 : 574–588. [CrossRef] [PubMed] [Google Scholar]
  3. Molla A, Couvet M, Coll JL. Unsuccessful mitosis in multicellular tumour spheroids. Oncotarget. 2017 ; 8 : 28769–28784. [CrossRef] [PubMed] [Google Scholar]
  4. Sontheimer-Phelps A, Hassell BA, Ingber DE. Modelling cancer in microfluidic human organs- on-chips. Nat Rev Cancer. 2019 ; 19 : 65–81. [CrossRef] [PubMed] [Google Scholar]
  5. Hassell BA, Goyal G, Lee E, et al. Human organ chip models recapitulate orthotopic lung cancer growth, therapeutic responses, and tumor dormancy in vitro. Cell Rep. 2017 ; 21 : 508–516. [CrossRef] [PubMed] [Google Scholar]
  6. Benam KH, Villenave R, Lucchesi C, et al. Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro. Nat Methods. 2016 ; 13 : 151–157. [CrossRef] [PubMed] [Google Scholar]
  7. Hsu TH, Xiao JL, Tsao YW, et al. Analysis of the paracrine loop between cancer cells and fibroblasts using a microfluidic chip. Lab Chip. 2011 ; 11 : 1808–1814. [CrossRef] [PubMed] [Google Scholar]
  8. Enewold L, Mechanic LE, Bowman ED, et al. Serum concentrations of cytokines and lung cancer survival in African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev. 2009 ; 18 : 215–222. [Google Scholar]
  9. Umekawa K, Kimura T, Kudoh S, et al. Plasma RANTES, IL-10, and IL-8 levels in non-small-cell lung cancer patients treated with EGFR-TKIs. BMC Res Notes. 2013 ; 6 : 139. [PubMed] [Google Scholar]
  10. Montagne R, Furlan A, Kherrouche Z, Tulasne D. Le récepteur Met fête ses 30 ans : de la découverte d’un oncogène au développement de thérapies ciblées. Med Sci (Paris). 2014 ; 30 : 864–873. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  11. Chabon JJ, Simmons AD, Lovejoy AF, et al. Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients. Nat Commun. 2016 ; 7 : 11815. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.